BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30783650)

  • 1. Tumour size determines both recurrence-free survival and disease-specific survival after surgical treatment for thymoma.
    Okumura M; Yoshino I; Yano M; Watanabe SI; Tsuboi M; Yoshida K; Date H; Yokoi K; Nakajima J; Toyooka SI; Asamura H; Miyaoka E
    Eur J Cardiothorac Surg; 2019 Jul; 56(1):174-181. PubMed ID: 30783650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of tumour size in completely resected thymic epithelial tumours.
    Fukui T; Fukumoto K; Okasaka T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Hirakawa A; Tateyama H; Yokoi K
    Eur J Cardiothorac Surg; 2016 Dec; 50(6):1068-1074. PubMed ID: 27999073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes following surgical treatment for thymic epithelial tumor in Japan and an analysis of prognostic factors based on the Japanese Association for Research on the Thymus nationwide database.
    Okumura M; Yoshino I; Funaki S; Okuda K; Watanabe SI; Tsuboi M; Shimizu K; Date H; Chen-Yoshikawa TF; Nakajima J; Toyooka S; Asamura H
    Surg Today; 2023 Nov; 53(11):1247-1259. PubMed ID: 37460670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of a new tumour-node-metastasis staging system for thymic malignancies proposed by the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and the International Thymic Malignancy Interest Group.
    Fukui T; Fukumoto K; Okasaka T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Hirakawa A; Tateyama H; Yokoi K
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):574-9. PubMed ID: 26547095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the prognostic role of neutrophil-to-lymphocyte ratio following complete resection of thymoma.
    Muriana P; Carretta A; Ciriaco P; Bandiera A; Negri G
    J Cardiothorac Surg; 2018 Nov; 13(1):119. PubMed ID: 30454002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different View on Tumor Size Dilemma in Tumor-Node-Metastasis Staging System for Thymoma.
    Cangir AK; Yenigün BM; Direk T; Kocaman G; Yücemen U; Kahya Y; Sak SD; Enön S
    Thorac Cardiovasc Surg; 2021 Mar; 69(2):148-156. PubMed ID: 32898892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of recurrent thymoma: is it worthwhile?†.
    Marulli G; Margaritora S; Lucchi M; Cardillo G; Granone P; Mussi A; Carleo F; Perissinotto E; Rea F
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):327-32. PubMed ID: 25755187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival and prognostic factors in thymic epithelial tumours.
    Rea F; Marulli G; Girardi R; Bortolotti L; Favaretto A; Galligioni A; Sartori F
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):412-8. PubMed ID: 15296907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the new TNM-staging system for thymic malignancies: impact on indication and survival.
    Ried M; Eicher MM; Neu R; Sziklavari Z; Hofmann HS
    World J Surg Oncol; 2017 Dec; 15(1):214. PubMed ID: 29197400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality therapy for locally advanced thymomas: A propensity score-matched cohort study from the European Society of Thoracic Surgeons Database.
    Leuzzi G; Rocco G; Ruffini E; Sperduti I; Detterbeck F; Weder W; Venuta F; Van Raemdonck D; Thomas P; Facciolo F;
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):47-57.e1. PubMed ID: 26403869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features of thymic carcinomas and the impact of histopathological agreement on prognostical studies.
    Roden AC; Yi ES; Cassivi SD; Jenkins SM; Garces YI; Aubry MC
    Eur J Cardiothorac Surg; 2013 Jun; 43(6):1131-9. PubMed ID: 23086701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study.
    Omasa M; Date H; Sozu T; Sato T; Nagai K; Yokoi K; Okamoto T; Ikeda N; Tanaka F; Maniwa Y;
    Cancer; 2015 Apr; 121(7):1008-16. PubMed ID: 25565590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the role of lymph nodal metastases and lymphadenectomy in the surgical treatment and prognosis of thymic carcinomas and carcinoids?
    Viti A; Bertolaccini L; Terzi A
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1054-8. PubMed ID: 25193970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after extended thymectomy for thymoma.
    Sakamoto M; Murakawa T; Konoeda C; Inoue Y; Kitano K; Sano A; Fukayama M; Nakajima J
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):623-7. PubMed ID: 22011779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study.
    Hishida T; Nomura S; Yano M; Asamura H; Yamashita M; Ohde Y; Kondo K; Date H; Okumura M; Nagai K;
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):835-41. PubMed ID: 26116920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term disease-free survival of patients with radically resected thymomas: relevance of cell-cycle protein expression.
    Mineo TC; Ambrogi V; Mineo D; Baldi A
    Cancer; 2005 Nov; 104(10):2063-71. PubMed ID: 16206298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoma: a review of the clinical and pathological findings in 65 cases.
    Sperling B; Marschall J; Kennedy R; Pahwa P; Chibbar R
    Can J Surg; 2003 Feb; 46(1):37-42. PubMed ID: 12585792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does surgical debulking for advanced stages of thymoma improve survival?
    Attaran S; Acharya M; Anderson JR; Punjabi PP
    Interact Cardiovasc Thorac Surg; 2012 Sep; 15(3):494-7. PubMed ID: 22700684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Masaoka stage and size are independent prognostic predictors in thymoma and modified Masaoka stage is superior to histopathologic classifications.
    Roden AC; Yi ES; Jenkins SM; Edwards KK; Donovan JL; Cassivi SD; Marks RS; Garces YI; Aubry MC
    J Thorac Oncol; 2015 Apr; 10(4):691-700. PubMed ID: 25629638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymoma. Analysis of prognostic factors.
    Sonobe M; Nakagawa M; Ichinose M; Ikegami N; Nagasawa M; Shindo T
    Jpn J Thorac Cardiovasc Surg; 2001 Jan; 49(1):35-41. PubMed ID: 11233240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.